4th Annual Genome Editing USA Congress

The congress will showcase the latest technologies, drugs and in vivo therapeutic solutions that are being produced by pioneers in the genome editing field. The congress will feature over 30 presentations in a comprehensive conference programme designed to provide an increased knowledge of current trends influencing gene editing research. Key speakers include Directors from Novartis, Pfizer, Harvard, MIT and more.

Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.

Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.

07 April 2019 – Day One